Bristol-Myers Squibb
BMY | NYSE
$62.48
+$1.09 (+1.78%)
At close: Oct 30, 2026, 4:00 PM ET
$62.32
-$0.16 (-0.26%)
Pre-market:
Nov 2, 2026, 7:16 AM ET
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.07B | 12.97B | 11.49B | 12.5B | 12.22B | 12.27B | 11.2B | 12.34B | 11.89B | 12.2B | 11.87B | 11.48B | 10.97B | 11.23B | 11.34B | 11.41B | 11.22B | 11.89B | 11.65B | 11.99B | 11.62B | 11.7B | 11.07B |
Cost of Revenue | 4.15B | 3.73B | 3.42B | 4.1B | 3.44B | 3.37B | 3.03B | 4.81B | 2.96B | 3.27B | 2.93B | 2.75B | 2.51B | 2.88B | 2.57B | 2.59B | 2.35B | 2.72B | 2.47B | 2.36B | 2.29B | 2.45B | 2.84B |
Gross Profit | 8.92B | 9.25B | 8.07B | 8.41B | 8.79B | 8.9B | 8.17B | 7.53B | 8.94B | 8.93B | 8.93B | 8.73B | 8.46B | 8.35B | 8.77B | 8.81B | 8.87B | 9.17B | 9.18B | 9.63B | 9.33B | 9.25B | 8.23B |
Operating Income | 2.84B | 4.03B | 3.37B | 2.81B | 3.64B | 3.77B | 3.5B | 510M | 2.17B | 1.69B | 1.51B | 1.9B | 1.96B | 1.9B | 2.43B | 1.69B | 2.1B | 2.64B | 2.67B | 2.25B | 2.02B | 2.34B | 1.83B |
Interest Income | n/a | 101M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.54B | 4.09B | 3.24B | 1.47B | 3.11B | 1.77B | 2.97B | 175M | 1.68B | 1.29B | -11.52B | 1.67B | 2.14B | 1.86B | 2.77B | 1.86B | 2.21B | 1.96B | 1.69B | 1.86B | 2.16B | 1.55B | 2.53B |
Net Income | 2.16B | 3.32B | 2.68B | 1.09B | 2.2B | 1.31B | 2.46B | 72M | 1.21B | 1.68B | -11.91B | 1.76B | 1.93B | 2.07B | 2.26B | 2.02B | 1.61B | 1.42B | 1.28B | 2.37B | 1.55B | 1.06B | 2.02B |
Selling & General & Admin | 1.7B | 1.83B | 1.62B | 2.18B | 1.79B | 1.71B | 1.58B | 2.14B | 1.98B | 1.93B | 2.37B | 2.07B | 2B | 1.93B | 1.76B | 2.27B | 1.93B | 1.79B | 1.83B | 2.35B | 1.79B | 1.88B | 1.67B |
Research & Development | 2.37B | 2.96B | 2.65B | 2.59B | 2.53B | 2.58B | 2.26B | 3.19B | 2.37B | 2.9B | 2.7B | 2.48B | 2.24B | 2.26B | 2.32B | 2.51B | 2.42B | 2.32B | 2.26B | 2.61B | 2.98B | 2.48B | 2.22B |
Other Expenses | 2.02B | 437M | 437M | 826M | 831M | 830M | 830M | 1.69B | 2.41B | 2.42B | 2.36B | 2.28B | 2.26B | 2.26B | 2.26B | 2.34B | 2.42B | 2.42B | 2.42B | 2.42B | 2.55B | 2.55B | 2.51B |
Operating Expenses | 6.08B | 5.22B | 4.7B | 5.59B | 5.15B | 5.12B | 4.67B | 7.02B | 6.76B | 7.24B | 7.42B | 6.83B | 6.5B | 6.45B | 6.34B | 7.12B | 6.77B | 6.53B | 6.51B | 7.38B | 7.31B | 6.91B | 6.4B |
Interest Expense | 403M | 407M | 411M | 432M | 480M | 485M | 494M | 496M | 505M | 521M | 425M | 316M | 280M | 282M | 288M | 294M | 299M | 313M | 326M | 323M | 328M | 330M | 353M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 1.58B | n/a | 1.98B | n/a | 2.37B | n/a | 2B | n/a | 1.76B | 2.27B | 1.93B | n/a | 1.83B | 2.35B | 1.79B | n/a | 1.67B |
Cost & Expenses | 10.23B | 8.95B | 8.12B | 9.69B | 8.58B | 8.5B | 7.7B | 11.83B | 9.72B | 10.51B | 10.35B | 9.57B | 9.01B | 9.33B | 8.91B | 9.71B | 9.12B | 9.25B | 8.98B | 9.73B | 9.61B | 9.36B | 9.24B |
Income Tax Expense | 374M | 770M | 561M | 384M | 919M | 460M | 509M | 99M | 461M | -398M | 392M | -88M | 203M | -218M | 503M | -166M | 601M | 529M | 404M | -514M | 605M | 492M | 501M |
Shares Outstanding (Basic) | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B | 2.03B | 2.03B | 2.02B | 2.03B | 2.06B | 2.09B | 2.1B | 2.11B | 2.13B | 2.13B | 2.15B | 2.15B | 2.22B | 2.23B | 2.24B |
Shares Outstanding (Diluted) | 2.05B | 2.05B | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B | 2.02B | 2.03B | 2.06B | 2.1B | 2.11B | 2.12B | 2.15B | 2.15B | 2.16B | 2.22B | 2.24B | 2.25B | 2.27B |
EPS (Basic) | 1.06 | 1.62 | 1.31 | 0.53 | 1.08 | 0.64 | 1.21 | 0.04 | 0.60 | 0.83 | -5.89 | 0.87 | 0.94 | 0.99 | 1.08 | 0.96 | 0.75 | 0.67 | 0.60 | 1.10 | 0.70 | 0.47 | 0.90 |
EPS (Diluted) | 1.05 | 1.62 | 1.31 | 0.53 | 1.08 | 0.64 | 1.20 | 0.04 | 0.60 | 0.83 | -5.89 | 0.87 | 0.93 | 0.99 | 1.07 | 0.95 | 0.75 | 0.66 | 0.59 | 1.07 | 0.69 | 0.47 | 0.89 |
EBITDA | 2.94B | 5.09B | 4.25B | 2.88B | 4.61B | 3.27B | 4.48B | 2.55B | 4.77B | 4.4B | -8.56B | 4.45B | 4.85B | 4.57B | 5.49B | 4.67B | 5.1B | 4.85B | 4.6B | 4.76B | 5.21B | 4.6B | 5.55B |
EBIT | 2.94B | 4.49B | 3.65B | 1.9B | 3.59B | 2.26B | 3.47B | 671M | 2.18B | 1.81B | -11.09B | 1.99B | 2.42B | 2.14B | 3.06B | 2.15B | 2.51B | 2.27B | 2.01B | 2.18B | 2.49B | 1.88B | 2.88B |
Depreciation & Amortization | n/a | 594M | 594M | 977M | 1.01B | 1.01B | 1.01B | 1.88B | 2.59B | 2.6B | 2.53B | 2.46B | 2.44B | 2.43B | 2.43B | 2.52B | 2.59B | 2.58B | 2.58B | 2.58B | 2.73B | 2.71B | 2.67B |
Add to Watchlist
Select watchlists to add or remove BMY